Drug Shortage Report for MYLAN-GABAPENTIN

Last updated on 2017-08-24 History
Report ID 7020
Drug Identification Number 02397498
Brand name MYLAN-GABAPENTIN
Common or Proper name GABAPENTIN
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) GABAPENTIN
Strength(s) 800MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100BT
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-04-11
Estimated end date
Actual end date 2017-08-23
Shortage status Resolved
Updated date 2017-08-24
Company comments Discontinuation reported under ID 20175.
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2017-08-24 French Compare
v5 2017-08-24 English Compare
v4 2017-05-05 French Compare
v3 2017-05-05 English Compare
v2 2017-04-13 French Compare
v1 2017-04-13 English Compare

Showing 1 to 6 of 6